Media statement: Two-year sporting ban for Rugby Union player Mitchell Spackman
21 March 2012
The Australian Rugby Union’s (ARU) decision to impose a two-year ban on amateur rugby player Mitchell Spackman for the attempted use of growth hormone releasing peptide (GHRP-6) was today acknowledged by the Australian Sports Anti-Doping Authority (ASADA).
The Australian Customs and Border Protection Service seized a package at the Sydney International Mail Gateway Facility on 4 March 2010 and notified ASADA.
Following an investigation by ASADA, the matter was referred to the ARU as a potential violation of its anti-doping code.
Mr Spackman’s ban, which was backdated to the date of his provisionalsuspension, means he is ineligible to participate as an athlete or support person until 1 December 2013 in any sports that have adopted a World Anti-Doping Agency compliant anti-doping policy.
GHRP-6 is not approved for human use in Australia. Anyone considering the use of this substance should be aware that it may involve potentially serious health consequences.
Possession, use or attempted use by athletes of this substance is also prohibited at all times under the World Anti-Doping Code (the Code). Penalties for breaching the Code can potentially include a lifetime ban for second offences.
GHRP-6 stimulates the anterior pituitary gland to secrete an increased amount of growth hormone following intake. A main role of growth hormone is to stimulate the protein, insulin-like growth factor 1 (known as IGF-1), which can promote bone, muscle and organ growth.
Any athletes unaware of their anti-doping responsibilities are encouraged to seek additional information online at ASADA's website.